These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17899303)

  • 1. Repeat transarterial chemoembolization (TACE) for progressive hepatic carcinoid metastases provides results similar to first TACE.
    Varker KA; Martin EW; Klemanski D; Palmer B; Shah MH; Bloomston M
    J Gastrointest Surg; 2007 Dec; 11(12):1680-5. PubMed ID: 17899303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience.
    Gupta S; Yao JC; Ahrar K; Wallace MJ; Morello FA; Madoff DC; Murthy R; Hicks ME; Ajani JA
    Cancer J; 2003; 9(4):261-7. PubMed ID: 12967136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic artery chemoembolization in 122 patients with metastatic carcinoid tumor: lessons learned.
    Bloomston M; Al-Saif O; Klemanski D; Pinzone JJ; Martin EW; Palmer B; Guy G; Khabiri H; Ellison EC; Shah MH
    J Gastrointest Surg; 2007 Mar; 11(3):264-71. PubMed ID: 17458596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
    Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
    Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors.
    Roche A; Girish BV; de Baère T; Baudin E; Boige V; Elias D; Lasser P; Schlumberger M; Ducreux M
    Eur Radiol; 2003 Jan; 13(1):136-40. PubMed ID: 12541121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk?
    Kitano M; Davidson GW; Shirley LA; Schmidt CR; Guy GE; Khabiri H; Dowell JD; Shah MH; Bloomston M
    Ann Surg Oncol; 2016 Nov; 23(12):4008-4015. PubMed ID: 27393568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrahepatic disease should not preclude transarterial chemoembolization for metastatic neuroendocrine carcinoma.
    Arrese D; McNally ME; Chokshi R; Feria-Arias E; Schmidt C; Klemanski D; Gregory G; Khabiri H; Shah M; Bloomston M
    Ann Surg Oncol; 2013 Apr; 20(4):1114-20. PubMed ID: 23456380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
    Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine hepatic metastases: does aggressive management improve survival?
    Touzios JG; Kiely JM; Pitt SC; Rilling WS; Quebbeman EJ; Wilson SD; Pitt HA
    Ann Surg; 2005 May; 241(5):776-83; discussion 783-5. PubMed ID: 15849513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complicated management of a patient following transarterial chemoembolization for metastatic carcinoid.
    Pearson AC; Steinberg S; Shah MH; Bloomston M
    World J Surg Oncol; 2008 Nov; 6():125. PubMed ID: 19032771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target lesion response predicts survival of patients with hepatocellular carcinoma retreated with transarterial chemoembolization.
    Zhang YF; Guo RP; OuYang HY; Shen JX; Zhao J; Tan GS; Le Y; Wei W; Shi M
    Liver Int; 2016 Oct; 36(10):1516-24. PubMed ID: 27105296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repetitive transarterial chemoembolization (TACE) of liver metastases from gastric cancer: local control and survival results.
    Vogl TJ; Gruber-Rouh T; Eichler K; Nour-Eldin NE; Trojan J; Zangos S; Naguib NN
    Eur J Radiol; 2013 Feb; 82(2):258-63. PubMed ID: 23127803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant TACE before laser induced thermotherapy (LITT) in the treatment of non-colorectal non-breast cancer liver metastases: feasibility and survival rates.
    Vogl TJ; Kreutzträger M; Gruber-Rouh T; Eichler K; Nour-Eldin NE; Zangos S; Naguib NN
    Eur J Radiol; 2014 Oct; 83(10):1804-10. PubMed ID: 25082479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis.
    Egger ME; Armstrong E; Martin RC; Scoggins CR; Philips P; Shah M; Konda B; Dillhoff M; Pawlik TM; Cloyd JM
    J Am Coll Surg; 2020 Apr; 230(4):363-370. PubMed ID: 32032719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer.
    Vogl TJ; Naguib NN; Nour-Eldin NE; Eichler K; Zangos S; Gruber-Rouh T
    Eur Radiol; 2010 Jan; 20(1):173-80. PubMed ID: 19657653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Randomized Clinical Trial.
    Yoon SM; Ryoo BY; Lee SJ; Kim JH; Shin JH; An JH; Lee HC; Lim YS
    JAMA Oncol; 2018 May; 4(5):661-669. PubMed ID: 29543938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy.
    Kuhlmann JB; Euringer W; Spangenberg HC; Breidert M; Blum HE; Harder J; Fischer R
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):437-43. PubMed ID: 22261548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
    Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period.
    Gruber-Rouh T; Naguib NN; Eichler K; Ackermann H; Zangos S; Trojan J; Beeres M; Harth M; Schulz B; Nour-Eldin A NE; Vogl TJ
    Int J Cancer; 2014 Mar; 134(5):1225-31. PubMed ID: 23960002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transarterial chemoembolization of liver metastases: Indication, technique, results].
    Vogl TJ; Zangos S; Balzer JO; Thalhammer A; Mack MG
    Rofo; 2002 Jun; 174(6):675-83. PubMed ID: 12063595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.